EyePoint (EYPT) Capital Expenditures Growth (5y) (2015 - 2025)
EyePoint (EYPT) Capital Expenditures Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.47% |
| Sep 30, 2025 | -28.45% |
| Jun 30, 2025 | -7.09% |
| Mar 31, 2025 | 22.42% |
| Dec 31, 2024 | 206.77% |
| Jun 30, 2024 | -70.95% |
| Mar 31, 2024 | 24.07% |
| Jun 30, 2023 | -67.03% |
| Mar 31, 2023 | 57.08% |
| Dec 31, 2022 | 53.68% |
| Sep 30, 2022 | 79.66% |
| Jun 30, 2022 | 11.59% |
| Mar 31, 2022 | 56.25% |
| Jun 30, 2021 | -26.04% |
| Dec 31, 2020 | 50.34% |
| Sep 30, 2020 | 63.37% |
| Jun 30, 2020 | -21.99% |
| Mar 31, 2020 | -17.94% |
| Dec 31, 2019 | -22.88% |
| Jun 30, 2019 | -32.08% |